We examined 24 C-type hepatitis specimens from Thailand and detected hepatitis C virus (HCV) RNA in all of them by RT-nested PCR for a portion of the HCV 5' non-coding (5' NC) region and a portion of the HCV core region. However, we failed to detect HCV RNA in 11 specimens by RT-nested PCR for a portion in the non-structural protein 5 (NSS) region that has been used commonly for HCV genotyping. We designed a new primer set for a separate portion of the NS5 region. Using this primer set, we succeeded in amplifying this portion in all 24 specimens. Two novel HCV genotypes, tentatively designated HCV-VII and HCV-VIII, were identified by sequencing these amplified regions. Our newly designed primers for RT-nested PCR may be useful for diagnosing infection as well as for genotyping unidentified HCV genomes.
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Hepatitis C virus (HCV) has a positive sense ssRNA genome. A partial HCV cDNA clone was first isolated by means of recombinant immunoscreening of a cDNA library derived from chimpanzee plasma with uncharacterized non-A, non-B hepatitis (Choo et al., 1989) . Since then, full-length nucleotide sequences of HCV genomes from numerous virus isolates have been determined (Kato et al., 1990; Choo et al., 1991 ; Takamizawa et al., 1991; Okamoto et al., 1991 Okamoto et al., , 1992 Chen et al., 1992; Inchauspe et al., 1991; Honda et al., 1992) . Like other RNA viruses, HCV genomes have shown considerable sequence variation between individual HCV isolates. More than ten different HCV genotypes have so far been identified world-wide (Okamoto et al., 1992; Mori et al., 1992; Simmonds et al., 1993; Tokita et al., 1994; Bukh et al., 1994) . Identification of these HCV genotypes is based mainly on the nucleotide sequence diversity and phylogenetic analysis of a specific portion of the HCV genome, i.e. the 5' non-coding (5' NC) region, the core region, the envelope glycoprotein 1 (El) region or the non-structural protein 5 (NS5) region. Although numerous classification systems for HCV sequences have been proposed, a unified nomenclature has been devised by Simmonds et al. (1993) .
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The nucleotide sequence data reported in this paper have been submitted to GenBank and assigned the accession numbers D28820 to D28858.
We previously identified two HCV genotypes designated HCV-V (3a) and HCV-VI (3b) (Mori et al., 1992) . In this study, to further clarify HCV genotypes, we examined another 24 C-type hepatitis specimens from Thailand by using RT-nested PCR and sequence analysis of the PCR products. RNA was extracted from plasma specimens as described previously (Kato et al., 1989) . Extracted RNA served as a template for cDNA synthesis with an antisense primer which was used also as an outer antisense primer for PCR . We used primers 196, 319R, 104 and 197R for 5' NC region PCR (Sekiya et al., 1994) . The primer sequences for the core region PCR were: TGATAGGGTGCTTGCGAGTG, 201 (outer sense); ATGTACCCCATGAGGTCGGC, 242R (outer antisense); CACGAATCCTAAACCTCA-AAG, 241 (inner sense); and GACAGGAGCCATCC-TGCCCA, 244R (inner antisense). For the NS5 region PCR we used outer primers 166 and 167, the sequences of which were the same as those described by Enomoto et al. (1990) , and type-specific inner primers for HCV-la (I)/lb (II), HCV-2a (III)/2b (IV) and HCV-3a (V)/3b (VI) as follows: TCACTGAGAATGACATCCGT, 173, ACTGAGAGAGACATCAGAAC, 151, TATACCAA-TGCTGTAACATT, 233, as sense primers, respectively; and ATGTGAGGGTATTACCGCAG, 174R, GTGA-TGGTGTTCCCCATGCT, 153R and GTGTTGCCG-AAGCTGGTAGG, 234R, as antisense primers, respectively. In addition, we designed new primers for another portion closer to the 3' end of the NS5 region: GAGTCTTCACGGAGGCTATGAC, 266 (outer 0001-3129 © 1995 SGM 33"3 33-3 32-2 32"2 32-5 33-I 32-5 32-2 32-2 32.5 33-3 30-6 4-9 2b(IV) J8 30"6 30"9 32"2 32.5 32.2 33"9 32.8 31.4 31.1 33"1 34-2 33.1 17.5 3a(V) TH36 16.7 27-9 27"3 27'9 29.2 28-1 26'5 27"9 27.3 26-8 27"6 32"0 3b(VI) T-9 27.9 27-6 28-1 28.4 27.9 27"1 27-6 27"9 27.1 29.8 33"6 VII TH13 2.5 2-7 4-4 3. Kato et al., 1990) ; JT, HCV-JT ; J33, HCV-J33 (GenBank accession number D01173); BK, HCV-BK (Takamizawa et al., 1991) ; JK1, HCV-JK1 (Honda et al., 1992) ; T, HCV-T (Chen et al., 1992) ; J6, HC-J6 (Okamoto et al., 1991) ; JS, HC-J8 (Okamoto et al., 1992) ; T-9, HCV-T-9 (Mori et al., 1992) .
t THII is classified as HCV-2a (IIl) on the basis of the sequence of this portion. sense); GCTGTGATATATGTCTCCCCC, 269R (outer antisense); GCTGCGTGGGAGACAGCTAGACAC, 267 (inner sense); and GTCCTTACTGCCCAGTTGA-AGAG, 268R (inner antisense). Basically, PCR was conducted using Pfu DNA polymerase (Stratagene) under conditions described previously (Kato et al., 1991) . We modified the conditions in part as follows: 55 °C, 45 s annealing in the first PCR for the 5' NC PCR; 55 °C, 45 s annealing and 2 min extension in the first PCR for the core region; and 2 min extension in the first PCR and 40 °C, 1 min annealing in the second PCR for the NS5 region. The PCR products were ligated into a plasmid vector, pTZ19R, and subcloned . Nucleotide sequences were determined using an AutoRead Sequencing Kit (Pharmacia). The nucleotide sequence data were submitted to the GenBank database (accession numbers D28820 to D28858). The nucleotide positions correspond to those of HCV-JT . We have cited in parallel in this paper two nomenclatures for HCV genotyping to avoid any confusion that might be caused by genotyping from partial sequencing. One nomenclature is that applied previously by Mori et al. (1992) and the other is that proposed by Simmonds et al. (1993) : HCV-I corresponds to HCV-la, HCV-II to HCV -lb, HCV-III to HCV-2a, HCV-IV to HCV-2b, HCV-V to HCV-3a and HCV-VI to HCV-3b. Firstly, we performed RT-nested PCR for the 5' NC region and confirmed the presence of HCV RNA in all 24 specimens. These specimens, except sample TH37, were also amplified for the core region. In order to classify the HCV genomes obtained into known genotypes by analysing the NS5 region, PCR was conducted with primers 166 and 167R followed by the second PCR with type-specific primers. In this way, 13 samples were typed: seven were HCV-la (I)/lb (II), two were HCV-2a (III)/2b (IV) and four were HCV-3a (V)/3b (VI). For the 11 samples in which the NS5 region could not be amplified, RT-nested PCR was performed for the other portion of the NS5 region with our newly designed primer set. We successfully amplified this portion of the NS5 region in all 11 specimens (TH3, TH9, TH11, TH13,  TH15, TH18, TH22, TH26, TH33, TH35 and TH37) .
Amplified fragments derived from these 11 specimens using the new primer set for the NS5 region were sequenced for 366 nucleotides (nt 8805-9170). On the basis of nucleotide sequence diversity, ten isolated clones were divided into two main types, tentatively called HCV-VII (TH13, TH15, TH18, TH22, TH26, TH35 and TH37) and HCV-VIII (TH3, TH9 and TH33) ( Table 1) . The nucleotide sequence diversity within the seven clones belonging to HCV-VII was less than 6 %. This degree of diversity is comparable to that within isolates belonging to HCV-1 b (II). The nucleotide sequence diversity within the three clones grouped in HCV-VIII was also low (less than 9%). The average nucleotide sequence diversity between HCV-VII and HCV-VIII was about 20%, which corresponds to the diversity between HCV-la (I) T  J6  J8  TH38  T-9 TH13 THI5 TH18 TH22 TH26 TH35 TH3 TH9 9.6 13.6 TH33 11-5 * 1, HCV-1 (Choo et al., 1991 ); H, HCV-H (Inchauspe et al., 1991) ; J, HCV-J (Kato et al., 1990) ; JT, HCV-JT ; J33, HCV-J33 (GenBank accession number D01173); BK, HCV-BK (Takamizawa et al., 1991) ; JK1, HCV-JK1 (Honda et al., 1992) ; T, HCV-T (Chen et aL, 1992); J6, HC-J6 (Okamoto et al., 1991) ; J8, HC-J8 (Okamoto et aL, 1992) ; T-9, HCV-T-9 (Mori et al., 1992) .
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and -lb (II) (17%), HCV-2a (III) and -2b (IV) (18%), and HCV-3a (V) and -3b (VI) (17%). By contrast, the nucleotide sequence diversity between HCV-VII/VIII and other HCV genotypes ranged from 27-34 % (Table  1) . These values correspond closely to the nucleotide sequence diversities between HCV-la (I)/lb (II) and HCV-2a (III)/2b (IV) (mean 34 %), HCV-la (I)/lb (II) and HCV-3a (V)/3b (VI) (mean 28 %), and HCV-2a (III)/2b (IV) and HCV-3a (V)/3b (VI) (mean 32%). Consequently, we considered HCV-VII and HCV-VIII to be novel HCV genotypes. In order to further characterize HCV-VII and HCV-VIII, we determined the partial nucleotide sequences of their core regions (251 bp, nt 368-618). The nucleotide sequence diversities in this region between HCV-VII/ VIII and other genotypes ranged from 16-20% (Table  2) . These values correspond to the diversities between HCV-la (I)/lb (II) and HCV-2a (III)/2b (IV) (mean 18%), HCV-la (I)/lb (II) and HCV-3a (V)/3b (VI) (mean 15%), and HCV-2a (III)/2b (IV) and HCV-3a (V)/3b (VI) (mean 21%). The average nucleotide sequence diversity between HCV-VII and HCV-VIII was about 16 %, higher than the diversities between HCV-la (I) and HCV-lb (II) (8.4 %), HCV-2a (III) and HCV-2b (IV) (10"4%), and HCV-3a (V) and HCV-3b (VI) (12.8 %). Moreover, HCV-VII and HCV-VIII diverged (11-23%) from HCV-lc, 2c, 3c-f, 4a-f, 5a and 6a in this portion (Table 3) .
Although the TH11 isolate could be classified as HCV2a(III) on the basis of the nucleotide sequence diversity in the newly amplified region of NS5 (Table 1) , the partial nucleotide sequence of the core region of TH11 diverged (19.9%) from that of HCV-2a(III) ( Table 2) . Furthermore, the sequence diversity between TH11 and other genotypes was greater than 11% (Tables 2 and 3 ). It is speculated that TH11 may belong to another new genotype on the basis of the core region sequence and that HCV cDNA obtained from THll might be a mixture of two different HCV genotypes, one unidentified and the other HCV-2a (III). We analysed several clones from the specimen from which TH11 was isolated, but failed to obtain evidence for the coexistence of two different genotypes in the respective amplified region. Thus, we cannot rule out the possibility that this particular result was due to different efficiencies of amplification between genotypes as well as between the regions of the HCV genome.
The nucleotide sequences of the 5' NC region (104 bp, nt 154-257) of HCV-VII and HCV-VIII were wellconserved compared with other genotypes of HCV already reported (data not shown). The nucleotide sequence diversity in this region between HCV-VII/VIII and HCV-1 a (I)/1 b (II) was relatively low (less than 7 %) compared with the diversities between HCV-VII/VIII and HCV-2a (III)/2b (IV) or HCV-3a (V)/3b (VI). Furthermore, the diversity between HCV-VII/VIII and type lc, 4a and 5a was relatively low (less than 5 %).
Although the diversity between TH33 and HCV-lb (II) was greater in the core region and the NS5 region, the nucleotide sequence in the region nt 154-257 (5' NC) of TH33 was identical to that of HCV-lb (II) (data not shown). To analyse the possibility that the viral genome Current genotyping is based mainly on comparisons of partial sequences in specific regions. The NS5 region contains a sequence that includes enough variability to allow genotyping and conserved franking sequences to anneal with PCR primers (Enomoto et al., 1990; primers 166 and 167R in this paper). However, we realized that the set of primers used for amplification of this region was not always successful. We established a new set of PCR primers, for amplification of another portion of the NS5 region, which worked well even in the specimens that could not be amplified by PCR using primers 166 and 167R. The new primers were designed to anneal as much as possible to nucleotide sequences in HCV-la (I), -lb (II), -2a (III), -2b (IV), -3a (V) and -3b (VI). Moreover, the amplified region was intended to include nucleotide sequence variations sufficient for genotyping. By using this primer set, we succeeded in amplifying 11 specimens which could not be amplified by PCR using the primers reported by Enomoto et al. (1992) . We also used RT-nested PCR to amplify 730 bp (nt 857-1586) of the E1 region (Bukh et al., 1994) but failed to amplify this region for all 11 specimens (data not shown). Therefore, the newly designed primer set seems more valuable for detecting HCV infection and typing the HCV genome, even for specimens in which PCR for the
